Rapid Dose Therapeutics (XCNQ:DOSE) Effective Interest Rate on Debt % : 51.80% (As of Feb. 2025)

View and export this data going back to 2010. Start your Free Trial

What is Rapid Dose Therapeutics Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Rapid Dose Therapeutics's annualized positive value of Interest Expense for the quarter that ended in Feb. 2025 was C$1.35 Mil. Rapid Dose Therapeutics's average total debt for the quarter that ended in Feb. 2025 was C$2.61 Mil. Therefore, Rapid Dose Therapeutics's annualized Effective Interest Rate on Debt % for the quarter that ended in Feb. 2025 was 51.80%.

Rapid Dose Therapeutics Effective Interest Rate on Debt % Historical Data

The historical data trend for Rapid Dose Therapeutics's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rapid Dose Therapeutics Effective Interest Rate on Debt % Chart

Rapid Dose Therapeutics Annual Data

Trend

Sep16

Sep17

Sep18

Feb19

Feb20

Feb21

Feb22

Feb23

Feb24

Feb25

Effective Interest Rate on Debt %

Get a 7-Day Free Trial

8.71

8.23

19.04

34.26

50.72

Rapid Dose Therapeutics Quarterly Data
	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24	Feb25
Effective Interest Rate on Debt %	Get a 7-Day Free Trial															48.76	50.46	37.38	53.36	51.80

Competitive Comparison of Rapid Dose Therapeutics's Effective Interest Rate on Debt %

For the Biotechnology subindustry, Rapid Dose Therapeutics's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rapid Dose Therapeutics's Effective Interest Rate on Debt % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Rapid Dose Therapeutics's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Rapid Dose Therapeutics's Effective Interest Rate on Debt % falls into.

Save Embed

;

Save Embed

;

Rapid Dose Therapeutics Effective Interest Rate on Debt % Calculation

Rapid Dose Therapeutics's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Feb. 2025 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (A: Feb. 2024 )	+	Total Debt (A: Feb. 2025 ))	/ count )
=	-1 * -1.232	/	( (2.248	+	2.61)	/ 2 )
=	-1 * -1.232	/	2.429
=	50.72 %

where

	Total Debt (A: Feb. 2024 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	2.125	+	0.123
=	2.248

	Total Debt (A: Feb. 2025 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	0	+	2.61
=	2.61

Rapid Dose Therapeutics's annualized Effective Interest Rate on Debt % for the quarter that ended in Feb. 2025 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (Q: Nov. 2024 )	+	Total Debt (Q: Feb. 2025 ))	/ count )
=	-1 * -1.352	/	( (2.61	+	2.61)	/ 2 )
=	-1 * -1.352	/	2.61
=	51.80 %

where

	Total Debt (Q: Nov. 2024 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	2.61	+	0
=	2.61

	Total Debt (Q: Feb. 2025 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	0	+	2.61
=	2.61

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Feb. 2025) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.

Rapid Dose Therapeutics (XCNQ:DOSE) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.

Rapid Dose Therapeutics Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of Rapid Dose Therapeutics's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.

Rapid Dose Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rapid Dose Therapeutics Corp (XCNQ:DOSE) » Definitions » Effective Interest Rate on Debt %

Comparable Companies

Traded in Other Exchanges

RDTCF:USA

Address

1121 Walkers Line, Unit 3, Burlington, ON, CAN, L7N 2G4

Website

https://www.rapid-dose.com

Rapid Dose Therapeutics Corp is a Canadian biotechnology company revolutionizing drug delivery through innovation. The company's flagship product QuickStrip is a thin, orally dissolvable film, that can be infused with an infinite list of active ingredients (nutraceuticals, pharmaceuticals, vaccines, and cannabis) that are delivered quickly into the bloodstream resulting in rapid onset of the active ingredient.

Executives

Mark Upsdell	Director
Brian Howlett	Director

Rapid Dose Therapeutics Headlines

No Headlines